Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

Abstract Background Currently, there is no standard treatment for managing relapse in patients with acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after allogeneic hematopoietic cell transplantation. Venetoclax-based therapies have been increasingly used for treating post-transplantat...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yufeng Du, Chunhong Li, Zhijia Zhao, Yikun Liu, Chengtao Zhang, Jinsong Yan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-08-01
Saila:	BMC Cancer
Gaiak:	Acute myeloid leukemia Myelodysplastic syndrome Venetoclax Hypomethylating agents Allogeneic hematopoietic cell transplantation Relapse
Sarrera elektronikoa:	https://doi.org/10.1186/s12885-023-11259-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!